![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/216 | (2006.01) |
A61K 31/185 | (2006.01) | ||
A61P 1/16 | (2006.01) | ||
A61P 13/12 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 2846791 |
(13) | Kind of document | T |
(96) | European patent application number | 12874745.8 |
Date of filing the European patent application | 2012-09-11 | |
(97) | Date of publication of the European application | 2015-03-18 |
(45) | Date of publication and mention of the grant of the patent | 2017-02-08 |
(46) | Date of publication of the claims translation | 2017-04-10 |
(86) | Number | PCT/US2012/054673 |
Date | 2012-09-11 |
(87) | Number | WO 2013/158145 |
Date | 2013-10-24 |
(30) | Number | Date | Country code |
201261636256 P | 2012-04-20 | US |
(72) |
SCHARSCHMIDT, Bruce, US
MOKHTARANI, Masoud, US
|
(73) |
Immedica Pharma AB,
Norrtullsgatan 15, 113 29 Stockholm,
SE
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | HPN-100, skirtas naudoti azoto susilaikymo sutrikimų gydymui |
HPN-100 FOR USE IN THE TREATMENT OF NITROGEN RETENTION DISORDERS |
Payment date | Validity (years) | Amount | |
2025-07-21 | 14 | 289.00 EUR |
2026-09-11 |